Bumetanide Tablet
Product Images NDC 72162-2197

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 72162-2197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

Chemical-structure.jpg (Chemical Structure)
Chemical structure of bumetanide, showing a benzene ring with attached carboxyl, sulfonamide, phenoxy, and butylamine functional groups.*
FDA Label Image

Label (Lbl721622197)

Label (Lbl721622197)
Bumetanide Tablets, USP 2 mg oral tablets label with NDC 72162-2197-5. The label states each tablet contains 2 mg Bumetanide. It is relabeled by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Sandoz Inc. The package size is 500 tablets. Storage instructions and warnings to keep tightly closed and out of reach of children are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.